Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2026)
Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Industry: Biotechnology

Value Growth Financials Momentum Sentiment Forecast Dividends Due Diligence

Biotech is Zen Rated F and is the 137th ranked industry out of 145 stock market industries

Ticker	Company	Price	1d %	1w %	1m %	3m %	6m %	1y %	3y %	5y %	10y %	52-week High	52-week Low	% off 52-week High	% off 52-week Low	Beta	Volume	Vol 1d %
CRVS	CORVUS PHARMACEUTICALS INC	$14.22	8.14%	0.99%	-21.87%	84.68%	115.13%	261.83%	2,087.69%	355.77%	3.04%	$26.95	$2.54	47.24%	459.84%	0.90	1,286,000	8.98%
ATAI	ATAIBECKLEY INC	$3.54	4.73%	-0.56%	-18.43%	-13.02%	-31.53%	125.48%	158.39%	N/A	N/A	$6.75	$1.15	47.56%	207.83%	1.44	3,233,000	-36.97%
EDSA	EDESA BIOTECH INC	$6.57	-6.41%	-14.56%	383.09%	356.25%	169.26%	163.86%	-9.32%	-81.78%	-99.59%	$9.37	$0.72	29.88%	812.50%	0.68	514,000	4.47%
HUMA	HUMACYTE INC	$0.82	3.65%	-22.36%	-29.05%	-23.08%	-48.88%	-71.37%	-74.60%	-92.23%	N/A	$2.93	$0.70	71.91%	17.40%	1.65	7,493,000	-3.39%
VERU	VERU INC	$2.29	0.00%	-0.43%	-11.58%	-4.58%	-36.21%	-55.75%	-82.11%	-98.05%	-88.43%	$7.40	$2.10	69.05%	9.05%	1.13	29,600	28.70%
CAPR	CAPRICOR THERAPEUTICS INC	$29.90	3.57%	-3.24%	5.47%	0.71%	358.59%	121.81%	627.49%	483.98%	13.26%	$40.37	$4.30	25.94%	595.35%	1.06	1,046,000	-4.65%
ELVN	ENLIVEN THERAPEUTICS INC	$35.53	14.06%	30.39%	21.35%	117.98%	91.33%	66.65%	53.81%	3.89%	N/A	$36.73	$13.30	3.25%	167.14%	1.10	6,420,000	431.02%
ALGS	ALIGOS THERAPEUTICS INC	$6.96	2.50%	0.14%	0.29%	-31.16%	-25.64%	-35.26%	-76.00%	-98.62%	N/A	$13.69	$3.76	49.16%	85.11%	1.46	28,400	-37.44%
PRME	PRIME MEDICINE INC	$3.63	3.13%	2.83%	-12.11%	3.71%	-30.46%	86.15%	-69.42%	N/A	N/A	$6.94	$1.11	47.69%	227.03%	1.96	2,257,000	2.92%
GHRS	GH RESEARCH PLC	$13.65	1.94%	-9.12%	-13.33%	8.33%	1.87%	8.94%	79.61%	N/A	N/A	$19.51	$7.98	30.04%	71.05%	1.02	72,600	-30.19%
MAZE	MAZE THERAPEUTICS INC	$31.73	-35.24%	-34.54%	-32.82%	-24.63%	20.42%	172.83%	N/A	N/A	N/A	$53.65	$6.71	40.86%	372.88%	0.88	7,832,000	1,324.00%
KYNB	KYNTRA BIO INC	$6.79	0.59%	-3.69%	-6.60%	-23.71%	-44.55%	-20.72%	-98.55%	-99.13%	-98.57%	$12.60	$4.85	46.11%	40.00%	1.45	13,500	-73.00%
BBOT	BRIDGEBIO ONCOLOGY THERAPEUTICS INC	$9.25	6.08%	4.17%	-10.19%	-24.98%	-21.74%	-13.23%	N/A	N/A	N/A	$14.87	$8.50	37.79%	8.82%	0.25	98,000	-22.22%
DNTH	DIANTHUS THERAPEUTICS INC	$79.61	1.35%	0.95%	53.48%	90.32%	122.13%	335.27%	529.83%	-60.94%	N/A	$88.02	$13.37	9.55%	495.66%	0.97	1,027,000	20.54%
PDSB	PDS BIOTECHNOLOGY CORP	$0.64	15.45%	-2.31%	-10.44%	-29.76%	-38.35%	-51.89%	-88.82%	-85.73%	-99.60%	$1.92	$0.52	66.84%	21.65%	1.92	817,000	38.71%
NUVL	NUVALENT INC	$98.00	1.92%	0.59%	-6.25%	-5.86%	26.42%	30.70%	249.13%	N/A	N/A	$113.02	$55.54	13.29%	76.47%	1.47	692,000	70.44%
CTNM	CONTINEUM THERAPEUTICS INC	$13.28	7.70%	8.67%	-15.84%	7.01%	22.28%	67.89%	N/A	N/A	N/A	$16.33	$3.35	18.68%	296.42%	0.73	129,000	-81.06%
IMNM	IMMUNOME INC	$20.30	0.45%	-1.55%	-8.31%	-6.49%	99.90%	192.09%	306.00%	-36.22%	N/A	$27.65	$5.15	26.58%	294.17%	1.46	1,443,000	22.08%
SVRA	SAVARA INC	$5.28	4.76%	4.76%	-9.59%	-18.14%	52.16%	90.61%	160.10%	216.17%	N/A	$7.01	$1.89	24.63%	179.37%	0.83	1,648,000	-15.40%
SXTP	60 DEGREES PHARMACEUTICALS INC	$1.55	9.15%	-26.89%	-49.51%	-44.32%	-72.12%	-79.50%	N/A	N/A	N/A	$17.68	$1.29	91.23%	20.16%	0.01	337,000	-42.00%
ACTU	ACTUATE THERAPEUTICS INC	$2.32	4.98%	-7.94%	-42.86%	-64.11%	-65.11%	-69.55%	N/A	N/A	N/A	$11.99	$2.15	80.65%	7.91%	0.94	122,000	35.56%
ABSI	ABSCI CORP	$2.92	-2.99%	2.10%	6.57%	-18.21%	10.19%	-4.89%	68.79%	N/A	N/A	$5.23	$2.01	44.15%	45.27%	2.19	7,135,000	53.37%
MLEC	MOOLEC SCIENCE SA	$6.66	-1.62%	-29.82%	-58.71%	84.79%	-61.05%	-93.96%	-98.99%	-99.54%	N/A	$157.05	$3.08	95.76%	116.51%	0.47	22,500	85.95%
XNCR	XENCOR INC	$12.40	4.29%	6.99%	3.51%	-18.53%	20.04%	4.91%	-55.90%	-71.70%	3.68%	$18.69	$6.92	33.65%	79.19%	1.18	638,000	-49.96%
INTS	INTENSITY THERAPEUTICS INC	$6.38	7.77%	-1.54%	-10.39%	-35.01%	2.90%	-87.43%	N/A	N/A	N/A	$51.73	$4.63	87.67%	37.74%	-0.19	29,600	-10.30%
ANRO	ALTO NEUROSCIENCE INC	$20.67	2.38%	-8.21%	8.85%	12.15%	443.95%	717.00%	N/A	N/A	N/A	$25.17	$1.60	17.88%	1,191.88%	1.11	186,000	31.91%
NBY	NOVABAY PHARMACEUTICALS INC	$1.42	-5.33%	10.94%	-8.39%	-94.14%	-86.73%	-53.44%	-99.51%	-99.98%	-99.99%	$99.75	$1.11	98.58%	27.93%	0.71	377,000	-68.69%
CING	CINGULATE INC	$6.36	-5.22%	-20.90%	-6.61%	52.15%	67.81%	59.00%	-97.30%	N/A	N/A	$11.89	$3.20	46.51%	98.75%	1.06	533,000	-7.63%
IMUX	IMMUNIC INC	$1.32	5.60%	14.78%	45.05%	135.29%	46.99%	5.60%	-13.73%	-90.81%	-99.62%	$1.51	$0.51	12.58%	160.87%	1.17	1,990,000	-19.47%
ZURA	ZURA BIO LTD	$5.62	4.46%	-6.18%	-19.71%	20.86%	167.62%	277.18%	-66.63%	N/A	N/A	$7.44	$0.97	24.46%	479.38%	0.33	749,000	42.67%
DRTS	ALPHA TAU MEDICAL LTD	$7.06	0.71%	-3.42%	-16.15%	38.43%	69.71%	165.41%	153.96%	-26.76%	N/A	$8.60	$2.30	17.91%	206.96%	0.50	211,000	50.71%
CRBP	CORBUS PHARMACEUTICALS HOLDINGS INC	$8.31	1.59%	-8.18%	6.95%	-0.24%	-31.55%	36.23%	21.85%	-86.15%	-84.61%	$20.56	$4.64	59.58%	79.09%	1.33	217,000	79.34%
PMVP	PMV PHARMACEUTICALS INC	$1.37	-1.44%	-8.05%	22.32%	10.48%	-2.14%	13.22%	-72.87%	-95.86%	N/A	$1.88	$0.81	27.13%	69.14%	1.21	407,000	23.33%
SABS	SAB BIOTHERAPEUTICS INC	$3.82	-1.29%	3.24%	-2.80%	1.06%	81.90%	135.80%	-18.50%	-96.08%	N/A	$6.60	$1.00	42.12%	282.00%	0.71	791,000	26.16%
IFRX	INFLARX NV	$0.94	-7.84%	6.82%	0.64%	-14.55%	-27.13%	-29.32%	-50.26%	-75.84%	N/A	$1.94	$0.71	51.55%	32.21%	0.80	386,000	25.32%
TERN	TERNS PHARMACEUTICALS INC	$52.86	5.72%	10.63%	27.74%	27.31%	610.48%	1,492.17%	459.96%	142.25%	N/A	$52.98	$1.87	0.23%	2,734.32%	0.91	81,316,000	3,095.13%
BNTC	BENITEC BIOPHARMA INC	$10.84	1.31%	-7.19%	-1.45%	-17.25%	-21.45%	-26.11%	219.58%	-88.55%	-96.46%	$17.15	$9.85	36.79%	10.05%	0.82	98,000	-20.97%
ONCY	ONCOLYTICS BIOTECH INC	$0.95	2.93%	-1.14%	-14.41%	-0.21%	-24.00%	49.61%	-23.08%	-72.78%	N/A	$1.51	$0.33	37.09%	191.41%	0.90	384,000	-2.29%
DYN	DYNE THERAPEUTICS INC	$18.98	6.33%	3.77%	17.96%	-5.29%	50.87%	66.49%	74.45%	29.29%	N/A	$25.00	$6.36	24.08%	198.43%	1.57	2,804,000	47.81%
FBRX	FORTE BIOSCIENCES INC	$26.38	2.57%	6.16%	-7.24%	-5.35%	85.12%	209.99%	8.11%	-96.35%	N/A	$35.62	$4.90	25.94%	438.37%	0.81	302,000	96.10%
MGX	METAGENOMI THERAPEUTICS INC	$1.39	1.46%	-3.47%	-10.32%	-18.24%	-39.57%	-12.58%	N/A	N/A	N/A	$3.95	$1.23	64.81%	13.01%	1.08	222,000	-8.64%
NKTX	NKARTA INC	$2.13	3.90%	-4.91%	-17.76%	15.76%	6.50%	48.95%	-38.97%	-94.05%	N/A	$2.81	$1.42	24.20%	50.00%	1.58	415,000	-22.14%
OCUL	OCULAR THERAPEUTIX INC	$8.33	2.84%	-1.88%	-12.32%	-33.68%	-31.94%	10.62%	62.06%	-53.80%	-4.03%	$16.44	$5.80	49.33%	43.62%	1.49	3,472,000	-4.72%
HOTH	HOTH THERAPEUTICS INC	$0.90	1.47%	-9.19%	-15.19%	-10.99%	-50.33%	-13.56%	-60.04%	-98.30%	N/A	$2.12	$0.66	57.49%	37.25%	0.79	101,000	-82.06%
RNAC	CARTESIAN THERAPEUTICS INC	$6.25	2.97%	-6.02%	-20.79%	-6.44%	-33.93%	-60.74%	-84.34%	-95.25%	N/A	$15.57	$5.98	59.86%	4.52%	1.56	151,000	-13.22%
ATRA	ATARA BIOTHERAPEUTICS INC	$4.96	-0.60%	-0.80%	-1.98%	-71.28%	-64.14%	-28.32%	-93.32%	-98.66%	-98.83%	$19.15	$3.92	74.09%	26.53%	1.93	64,500	-34.85%
IMMX	IMMIX BIOPHARMA INC	$8.91	3.97%	-5.81%	1.83%	57.98%	336.76%	381.62%	379.03%	N/A	N/A	$11.61	$1.34	23.26%	564.93%	1.08	769,000	28.38%
PMN	PROMIS NEUROSCIENCES INC	$15.85	-9.06%	-6.76%	-20.19%	106.92%	58.50%	-4.37%	-85.12%	N/A	N/A	$39.75	$6.27	60.13%	152.79%	0.46	21,000	28.05%
BTAI	BIOXCEL THERAPEUTICS INC	$1.43	0.00%	-13.33%	-13.86%	-13.86%	-49.29%	-36.30%	-99.50%	-99.78%	N/A	$8.08	$1.17	82.30%	22.22%	1.64	460,000	-1.71%
APGE	APOGEE THERAPEUTICS INC	$78.53	7.58%	17.61%	10.78%	1.56%	109.30%	96.87%	N/A	N/A	N/A	$85.04	$26.20	7.66%	199.73%	1.29	3,486,000	62.82%
CLNN	CLENE INC	$5.48	-4.36%	-16.59%	10.48%	-12.32%	-6.72%	58.38%	-76.17%	-98.02%	N/A	$13.50	$2.28	59.41%	140.35%	0.76	69,000	2.99%
ANNX	ANNEXON INC	$5.37	7.30%	-1.01%	5.40%	4.99%	92.29%	117.21%	38.27%	-81.58%	N/A	$7.18	$1.29	25.28%	317.51%	1.13	2,174,000	-19.93%
KROS	KEROS THERAPEUTICS INC	$11.34	3.18%	3.56%	-25.49%	-46.08%	-28.23%	0.44%	-72.83%	-80.85%	N/A	$22.55	$9.12	49.71%	24.34%	1.12	352,000	-23.64%
REPL	REPLIMUNE GROUP INC	$7.56	8.46%	11.83%	-7.80%	-24.10%	86.67%	-29.28%	-60.71%	-76.19%	N/A	$13.24	$2.68	42.90%	182.09%	1.06	2,107,000	26.77%
RAPP	RAPPORT THERAPEUTICS INC	$28.88	2.23%	9.06%	-4.37%	-4.37%	15.66%	187.36%	N/A	N/A	N/A	$42.27	$7.73	31.68%	273.61%	1.36	306,000	61.90%
ALEC	ALECTOR INC	$2.17	4.33%	5.85%	-9.21%	49.66%	-25.94%	68.22%	-65.61%	-86.34%	N/A	$3.40	$0.87	36.18%	149.43%	1.66	589,000	-0.84%
SPRB	SPRUCE BIOSCIENCES INC	$69.97	8.72%	19.10%	19.14%	-18.39%	802.84%	188.83%	-59.61%	-94.57%	N/A	$240.00	$4.28	70.85%	1,536.73%	1.44	99,000	193.77%
OMER	OMEROS CORP	$10.44	2.55%	-4.66%	-8.26%	-33.55%	138.36%	13.97%	159.06%	-46.73%	-28.25%	$17.65	$2.95	40.85%	253.90%	1.51	632,000	-33.96%
RVPH	REVIVA PHARMACEUTICALS HOLDINGS INC	$0.83	0.24%	-55.67%	-81.20%	-86.49%	-85.95%	-96.33%	-99.01%	-99.24%	N/A	$23.20	$0.67	96.43%	23.73%	0.84	529,000	-26.01%
TIL	INSTIL BIO INC	$8.60	0.47%	3.12%	0.58%	-23.96%	-48.35%	-53.16%	-30.33%	-98.23%	N/A	$42.79	$5.67	79.90%	51.68%	1.74	12,500	-10.07%
QSI	QUANTUM-SI INC	$0.87	1.65%	-1.93%	-12.63%	-29.67%	-42.72%	-38.65%	-47.58%	-92.30%	N/A	$3.10	$0.79	72.10%	9.22%	2.17	2,539,000	-2.98%
KYMR	KYMERA THERAPEUTICS INC	$78.93	6.06%	-0.27%	-12.96%	-2.94%	46.89%	148.05%	173.97%	99.47%	N/A	$103.00	$19.45	23.37%	305.91%	1.64	924,000	54.77%
PGEN	PRECIGEN INC	$3.10	-0.96%	-5.20%	-19.27%	-25.48%	-11.05%	81.29%	253.08%	-59.79%	-91.02%	$5.47	$1.11	43.28%	179.28%	1.79	5,960,000	15.84%
PRAX	PRAXIS PRECISION MEDICINES INC	$311.92	5.86%	8.01%	-10.25%	15.98%	533.34%	769.83%	2,210.52%	-35.54%	N/A	$356.00	$26.70	12.38%	1,068.24%	1.03	349,000	-28.78%
NMRA	NEUMORA THERAPEUTICS INC	$2.50	1.21%	-5.30%	-27.75%	40.45%	47.06%	119.30%	N/A	N/A	N/A	$3.65	$0.61	31.51%	309.17%	1.40	766,000	53.51%
MBRX	MOLECULIN BIOTECH INC	$2.49	10.67%	19.71%	-3.49%	-34.99%	-77.35%	-91.34%	-99.31%	-99.83%	N/A	$28.61	$1.79	91.30%	39.11%	0.86	200,000	26.58%
DMAC	DIAMEDICA THERAPEUTICS INC	$6.86	-0.44%	-3.65%	-19.29%	-16.65%	0.29%	50.11%	341.16%	-29.93%	N/A	$10.42	$3.19	34.16%	115.05%	0.89	198,000	-5.71%
CVKD	CADRENAL THERAPEUTICS INC	$5.42	-5.41%	-25.14%	-37.20%	-26.86%	-61.83%	-72.21%	-71.77%	N/A	N/A	$19.03	$4.91	71.52%	10.39%	0.88	98,000	-28.99%
COGT	COGENT BIOSCIENCES INC	$36.50	4.41%	6.20%	-8.68%	-6.12%	174.64%	428.99%	251.98%	316.67%	N/A	$43.73	$3.72	16.53%	881.18%	1.20	2,298,000	21.07%
OCS	OCULIS HOLDING AG	$25.00	1.96%	-4.94%	-15.43%	21.95%	42.86%	27.03%	257.65%	150.00%	N/A	$30.68	$14.00	18.51%	78.57%	0.28	323,000	50.93%
PASG	PASSAGE BIO INC	$7.10	6.05%	0.92%	-23.87%	-34.67%	-7.62%	-27.90%	-65.56%	-97.93%	N/A	$20.00	$5.12	64.53%	38.47%	1.57	30,300	-5.31%
CRSP	CRISPR THERAPEUTICS AG	$47.09	1.42%	-1.26%	-14.69%	-14.51%	-21.93%	15.16%	6.18%	-58.91%	N/A	$78.48	$30.04	40.00%	56.76%	1.52	1,079,000	-6.98%
MNPR	MONOPAR THERAPEUTICS	$56.95	3.08%	-2.32%	2.39%	-17.19%	-26.46%	51.54%	282.21%	81.08%	N/A	$105.00	$26.06	45.76%	118.58%	0.76	250,000	98.41%
DFTX	DEFINIUM THERAPEUTICS INC	$18.47	3.82%	4.71%	4.82%	41.42%	89.05%	172.42%	534.71%	-49.74%	N/A	$19.67	$4.70	6.10%	292.98%	1.68	2,485,000	91.30%
ELDN	ELEDON PHARMACEUTICALS INC	$2.92	1.04%	-2.67%	18.22%	82.50%	18.22%	-15.85%	25.86%	-75.00%	-99.65%	$4.60	$1.35	36.52%	116.30%	0.77	927,000	-32.14%
TECX	TECTONIC THERAPEUTIC INC	$31.06	3.29%	-3.39%	34.40%	48.75%	111.15%	46.37%	135.30%	-78.21%	N/A	$36.03	$13.70	13.79%	126.72%	1.23	204,000	64.52%
ARTV	ARTIVA BIOTHERAPEUTICS INC	$5.46	4.40%	-5.86%	8.55%	30.62%	81.40%	36.84%	N/A	N/A	N/A	$7.75	$1.47	29.58%	271.43%	1.43	56,000	-28.21%
GNPX	GENPREX INC	$1.94	2.65%	-3.48%	-3.48%	8.38%	-79.06%	-89.95%	-99.90%	-99.98%	N/A	$55.00	$1.71	96.47%	13.45%	1.19	198,000	12.50%
XENE	XENON PHARMACEUTICALS INC	$55.57	4.10%	0.91%	24.67%	23.93%	52.16%	59.23%	61.35%	210.10%	733.13%	$63.95	$26.74	13.10%	107.82%	0.86	1,717,000	55.38%
ARMP	ARMATA PHARMACEUTICALS INC	$8.61	4.87%	0.82%	-19.00%	30.85%	188.93%	412.50%	438.13%	67.51%	-98.57%	$16.34	$0.90	47.31%	858.80%	0.38	35,700	87.89%
ENTX	ENTERA BIO LTD	$1.18	14.56%	-11.94%	-25.32%	-31.40%	-34.08%	-37.23%	14.56%	-70.50%	N/A	$3.22	$0.98	63.35%	20.41%	0.48	285,000	185.00%
BNTX	BIONTECH SE	$88.77	2.26%	-1.37%	-19.18%	-6.08%	-9.49%	-8.53%	-28.18%	-6.69%	N/A	$124.00	$79.52	28.41%	11.63%	0.96	642,000	-37.55%
BCTX	BRIACELL THERAPEUTICS CORP	$4.05	-1.22%	-6.03%	3.85%	-47.67%	-62.18%	-90.10%	-99.62%	-99.19%	N/A	$98.20	$3.60	95.88%	12.50%	0.98	181,000	74.04%
CLYM	CLIMB BIO INC	$6.98	4.49%	-1.97%	-1.55%	41.58%	232.38%	436.92%	116.10%	N/A	N/A	$8.03	$1.05	13.04%	564.76%	0.83	536,000	3.88%
AVIR	ATEA PHARMACEUTICALS INC	$5.43	1.88%	-8.12%	17.53%	48.77%	86.60%	69.69%	71.84%	-90.94%	N/A	$6.45	$2.46	15.81%	121.18%	0.98	420,000	-38.05%
CNTX	CONTEXT THERAPEUTICS INC	$2.67	-16.04%	-8.56%	9.88%	136.28%	195.68%	208.67%	313.31%	N/A	N/A	$3.62	$0.49	26.24%	444.90%	0.91	1,720,000	152.57%
SRRK	SCHOLAR ROCK HOLDING CORP	$45.43	7.40%	14.17%	-3.28%	-0.53%	31.72%	36.51%	467.17%	-15.65%	N/A	$49.82	$22.71	8.81%	100.04%	1.02	1,695,000	-20.72%
RADX	RADIOPHARM THERANOSTICS LTD	$4.33	4.59%	-7.87%	-15.10%	-21.27%	-24.70%	-21.98%	N/A	N/A	N/A	$16.25	$3.50	73.35%	23.86%	0.61	220,000	-96.88%
KOD	KODIAK SCIENCES INC	$22.75	4.12%	3.03%	-17.63%	-23.89%	45.09%	609.83%	361.46%	-80.95%	N/A	$31.18	$1.92	27.04%	1,084.90%	1.95	759,000	51.20%
DNLI	DENALI THERAPEUTICS INC	$22.47	7.15%	12.01%	0.81%	33.20%	67.31%	59.14%	-3.44%	-59.59%	N/A	$23.77	$10.57	5.47%	112.58%	1.60	5,399,000	233.07%
CTMX	CYTOMX THERAPEUTICS INC	$4.22	-0.47%	-4.09%	-26.99%	-3.87%	48.59%	586.18%	135.75%	-46.85%	-66.27%	$8.21	$0.40	48.60%	955.00%	1.39	6,112,000	9.77%
SANA	SANA BIOTECHNOLOGY INC	$3.10	6.16%	-0.96%	-25.66%	-29.71%	-8.55%	44.19%	-7.19%	-89.84%	N/A	$6.55	$1.26	52.67%	146.03%	2.08	3,299,000	-26.98%
MSLE	SATELLOS BIOSCIENCE INC	$7.12	0.71%	-1.11%	-38.78%	N/A	N/A	N/A	N/A	N/A	N/A	$13.40	$6.67	46.85%	6.75%	2.07	48,000	14.29%
MCRB	SERES THERAPEUTICS INC	$9.14	10.39%	1.22%	2.81%	-37.61%	-51.64%	-35.81%	-91.63%	-97.64%	-98.13%	$29.98	$6.53	69.51%	39.97%	1.25	46,000	22.02%
EPRX	EUPRAXIA PHARMACEUTICALS INC	$7.08	2.76%	-5.73%	-12.05%	-6.23%	22.92%	100.00%	N/A	N/A	N/A	$9.32	$2.68	24.03%	164.18%	0.65	154,000	-18.95%
BCAX	BICARA THERAPEUTICS INC	$18.68	2.86%	1.47%	6.68%	11.19%	74.58%	43.36%	N/A	N/A	N/A	$20.24	$7.80	7.71%	139.49%	1.51	361,000	-17.20%
NGNE	NEUROGENE INC	$22.03	5.41%	12.97%	9.66%	10.09%	26.57%	55.14%	65.81%	-90.57%	-86.74%	$37.27	$6.88	40.88%	220.44%	1.45	178,000	-39.86%
RVMD	REVOLUTION MEDICINES INC	$94.29	-1.29%	-3.89%	-8.67%	16.77%	121.81%	145.23%	348.36%	107.37%	N/A	$124.49	$29.17	24.26%	223.24%	1.29	2,420,000	60.90%
ELAB	PMGC HOLDINGS INC	$1.82	-37.02%	-57.77%	-73.85%	-95.11%	-98.49%	-99.56%	N/A	N/A	N/A	$466.20	$1.75	99.61%	4.00%	1.41	1,056,000	-94.60%
VRDN	VIRIDIAN THERAPEUTICS INC	$28.35	4.27%	2.24%	-2.04%	-11.07%	48.58%	91.55%	10.61%	64.16%	-75.28%	$34.29	$9.90	17.32%	186.36%	0.93	951,000	-31.24%

Biotech Stocks FAQ

What are the best biotech stocks to buy right now in Mar 2026?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best biotechnology stocks to buy right now are:

1. Veracyte (NASDAQ:VCYT)

Veracyte (NASDAQ:VCYT) is the #1 top biotech stock out of 605 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Veracyte (NASDAQ:VCYT) is: Value: B, Growth: A, Momentum: C, Sentiment: A, Safety: B, Financials: B, and AI: C.

Veracyte (NASDAQ:VCYT) has a Due Diligence Score of 59, which is 34 points higher than the biotech industry average of 25.

VCYT passed 19 out of 33 due diligence checks and has strong fundamentals. Veracyte has seen its stock lose -2.67% over the past year, overperforming other biotech stocks by 32 percentage points.

Veracyte has an average 1 year price target of $45.17, an upside of 37.75% from Veracyte's current stock price of $32.79.

Veracyte stock has a consensus Buy recommendation according to Wall Street analysts. Of the 6 analysts covering Veracyte, 50% have issued a Strong Buy rating, 16.67% have issued a Buy, 16.67% have issued a hold, while 0% have issued a Sell rating, and 16.67% have issued a Strong Sell.

2. Pharming Group Nv (NASDAQ:PHAR)

Pharming Group Nv (NASDAQ:PHAR) is the #2 top biotech stock out of 605 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Pharming Group Nv (NASDAQ:PHAR) is: Value: B, Growth: B, Momentum: B, Sentiment: B, Safety: C, Financials: B, and AI: C.

Pharming Group Nv (NASDAQ:PHAR) has a Due Diligence Score of 30, which is 5 points higher than the biotech industry average of 25.

PHAR passed 9 out of 33 due diligence checks and has average fundamentals. Pharming Group Nv has seen its stock return 86.1% over the past year, overperforming other biotech stocks by 121 percentage points.

Pharming Group Nv has an average 1 year price target of $39.00, an upside of 140.3% from Pharming Group Nv's current stock price of $16.23.

Pharming Group Nv stock has a consensus Buy recommendation according to Wall Street analysts. Of the 2 analysts covering Pharming Group Nv, 0% have issued a Strong Buy rating, 100% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Jazz Pharmaceuticals (NASDAQ:JAZZ)

Jazz Pharmaceuticals (NASDAQ:JAZZ) is the #3 top biotech stock out of 605 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Jazz Pharmaceuticals (NASDAQ:JAZZ) is: Value: B, Growth: A, Momentum: C, Sentiment: C, Safety: C, Financials: B, and AI: B.

Jazz Pharmaceuticals (NASDAQ:JAZZ) has a Due Diligence Score of 16, which is -9 points lower than the biotech industry average of 25. Although this number is below the industry average, our proven quant model rates JAZZ as a "A".

JAZZ passed 5 out of 33 due diligence checks and has weak fundamentals. Jazz Pharmaceuticals has seen its stock return 39.8% over the past year, overperforming other biotech stocks by 74 percentage points.

Jazz Pharmaceuticals has an average 1 year price target of $223.91, an upside of 18.42% from Jazz Pharmaceuticals's current stock price of $189.08.

Jazz Pharmaceuticals stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 11 analysts covering Jazz Pharmaceuticals, 63.64% have issued a Strong Buy rating, 27.27% have issued a Buy, 9.09% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the biotech stocks with highest dividends?

Out of 6 biotech stocks that have issued dividends in the past year, the 3 biotech stocks with the highest dividend yields are:

1. Novabay Pharmaceuticals (NYSEMKT:NBY)

Novabay Pharmaceuticals (NYSEMKT:NBY) has an annual dividend yield of 281.69%, which is 242 percentage points higher than the biotech industry average of 39.49%.

Novabay Pharmaceuticals's dividend payout ratio of -105.3% indicates that its high dividend yield might not be sustainable for the long-term.

2. Dominari Holdings (NASDAQ:DOMH)

Dominari Holdings (NASDAQ:DOMH) has an annual dividend yield of 21.04%, which is -18 percentage points lower than the biotech industry average of 39.49%.

Dominari Holdings's dividend payout ratio of 8.4% indicates that its high dividend yield is sustainable for the long-term.

3. Oramed Pharmaceuticals (NASDAQ:ORMP)

Oramed Pharmaceuticals (NASDAQ:ORMP) has an annual dividend yield of 7.14%, which is -32 percentage points lower than the biotech industry average of 39.49%.

Oramed Pharmaceuticals's dividend payout ratio of 0% indicates that its high dividend yield might not be sustainable for the long-term.

Why are biotech stocks up?

Biotech stocks were up 2.92% in the last day, and up 1.12% over the last week. Sarepta Therapeutics was the among the top gainers in the biotechnology industry, gaining 34.98% yesterday.

Sarepta Therapeutics shares are trading higher after the company announced that early results from Phase 1/2 studies of SRP-1001 for facioscapulohumeral muscular dystrophy type 1 and SRP-1003 for myotonic dystrophy type 1. Also, the company generated proof-of-concept data for SRP-1001 and SRP-1003.

What are the most undervalued biotech stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued biotech stocks right now are:

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

Harmony Biosciences Holdings (NASDAQ:HRMY) is the most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harmony Biosciences Holdings has a valuation score of 71, which is 56 points higher than the biotech industry average of 15. It passed 5 out of 7 valuation due diligence checks.

Harmony Biosciences Holdings's stock has dropped -16.37% in the past year. It has overperformed other stocks in the biotech industry by 18 percentage points.

2. Incyte (NASDAQ:INCY)

Incyte (NASDAQ:INCY) is the second most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Incyte has a valuation score of 71, which is 56 points higher than the biotech industry average of 15. It passed 5 out of 7 valuation due diligence checks.

Incyte's stock has gained 48.57% in the past year. It has overperformed other stocks in the biotech industry by 83 percentage points.

3. Exelixis (NASDAQ:EXEL)

Exelixis (NASDAQ:EXEL) is the third most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Exelixis has a valuation score of 43, which is 28 points higher than the biotech industry average of 15. It passed 3 out of 7 valuation due diligence checks.

Exelixis's stock has gained 13.46% in the past year. It has overperformed other stocks in the biotech industry by 48 percentage points.

Are biotech stocks a good buy now?

63.68% of biotech stocks rated by analysts are a strong buy right now. On average, analysts expect biotech stocks to rise by 67.6% over the next year.

2.4% of biotech stocks have a Zen Rating of A (Strong Buy), 4.37% of biotech stocks are rated B (Buy), 47.38% are rated C (Hold), 34.28% are rated D (Sell), and 11.57% are rated F (Strong Sell).

What is the average p/e ratio of the biotechnology industry?

The average P/E ratio of the biotechnology industry is 25.57x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.

Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2026)
Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Biotech Stocks FAQ

1. Veracyte (NASDAQ:VCYT)

2. Pharming Group Nv (NASDAQ:PHAR)

3. Jazz Pharmaceuticals (NASDAQ:JAZZ)

1. Novabay Pharmaceuticals (NYSEMKT:NBY)

2. Dominari Holdings (NASDAQ:DOMH)

3. Oramed Pharmaceuticals (NASDAQ:ORMP)

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

2. Incyte (NASDAQ:INCY)

3. Exelixis (NASDAQ:EXEL)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcareBiotechnologyBest Biotech Stocks to Buy Now (2026)Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Biotech Stocks FAQ

1. Veracyte (NASDAQ:VCYT)

2. Pharming Group Nv (NASDAQ:PHAR)

3. Jazz Pharmaceuticals (NASDAQ:JAZZ)

1. Novabay Pharmaceuticals (NYSEMKT:NBY)

2. Dominari Holdings (NASDAQ:DOMH)

3. Oramed Pharmaceuticals (NASDAQ:ORMP)

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

2. Incyte (NASDAQ:INCY)

3. Exelixis (NASDAQ:EXEL)

Company

Stock Tools

Stock Ideas

Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2026)
Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.